Parametrica Management LTD Iovance Biotherapeutics, Inc. Transaction History

Parametrica Management LTD

$83.5 Million
Q3 2024

A detailed history of Parametrica Management LTD transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Parametrica Management LTD holds 261,090 shares of IOVA stock, worth $1.93 Million. This represents 2.93% of its overall portfolio holdings.

Number of Shares

261,090

Previous 261,090 -0.0%

Holding current value

$1.93 Million

Previous $2.09 Million 17.1%

% of portfolio

2.93%

Previous 2.77%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$7.78 - $14.19 $1.01 Million - $1.84 Million	129,500 Added 98.41%	261,090 $2.09 Million
Q1 2024 May 10, 2024	SELL	$7.59 - $17.47 $1.43 Million - $3.3 Million	-188,686 Reduced 58.91%	131,590 $1.95 Million
Q4 2023 Feb 02, 2024	BUY	$3.3 - $8.89 $742,090 - $2 Million	224,876 Added 235.72%	320,276 $2.6 Million
Q3 2023 Oct 31, 2023	SELL	$4.44 - $8.79 $4,884 - $9,668	-1,100 Reduced 1.14%	95,400 $434,000
Q2 2023 Aug 02, 2023	BUY	$5.36 - $9.06 $256,208 - $433,068	47,800 Added 98.15%	96,500 $679,000
Q1 2023 May 09, 2023	BUY	$5.53 - $8.22 $4,424 - $6,576	800 Added 1.67%	48,700 $297,000
Q4 2022 Feb 07, 2023	SELL	$5.62 - $10.0 $262,735 - $467,500	-46,750 Reduced 49.39%	47,900 $306,000
Q3 2022 Nov 02, 2022	SELL	$9.53 - $13.11 $202,226 - $278,194	-21,220 Reduced 18.31%	94,650 $907,000
Q2 2022 Jul 22, 2022	SELL	$6.38 - $18.33 $120,001 - $344,768	-18,809 Reduced 13.97%	115,870 $1.27 Million
Q1 2022 May 10, 2022	SELL	$12.38 - $19.1 $179,534 - $276,988	-14,502 Reduced 9.72%	134,679 $2.24 Million
Q4 2021 Feb 15, 2022	BUY	$16.55 - $27.63 $46,654 - $77,888	2,819 Added 1.93%	149,181 $2.85 Million
Q3 2021 Nov 12, 2021	BUY	$20.35 - $26.63 $1.47 Million - $1.92 Million	72,087 Added 97.05%	146,362 $3.61 Million
Q2 2021 Aug 13, 2021	BUY	$16.33 - $33.07 $1.21 Million - $2.46 Million	74,275 New	74,275 $1.93 Million
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $242,923 - $317,770	-8,754 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$27.21 - $41.0 $238,196 - $358,914	8,754 New	8,754 $240,000

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.16B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parametrica Management LTD with notifications on news.

Account

Parametrica Management LTD Iovance Biotherapeutics, Inc. Transaction History